CVS vs ELV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

CVS

38.8
AI Score
VS
CVS Wins

ELV

31.4
AI Score

Investment Advisor Scores

CVS

39score
Recommendation
AVOID NEW MONEY

ELV

31score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric CVS ELV Winner
Forward P/E 10.6724 13.6799 CVS
PEG Ratio 0.2113 1.3035 CVS
Revenue Growth 7.1% 1.4% CVS
Earnings Growth 188.8% -13.1% CVS
Tradestie Score 38.8/100 31.4/100 CVS
Profit Margin 1.2% 2.5% ELV
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY EXTENDED ELV

Relative Price Performance (Last 90 Days)

CVS 1M: +10.0% · 3M: -12.3% ELV 1M: +11.7% · 3M: +17.9%

Current Technical Phase

CVS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 62

RSI (14): 61.5 · Price: $94.48

ELV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.8% over 20 days), RSI 72

RSI (14): 71.5 · Price: $445.28

Fundamentals Snapshot

Metric CVS ELV
Market Cap — —
Forward P/E 11.1 15.0
Trailing P/E 24.6 18.4
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.1% 0.3%
Operating Margin 0.0% 0.0%
EPS 3.80 23.55
Dividend Yield 0.03% 0.00%

Frequently Asked Questions

Based on our detailed analysis, CVS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.